[HTML][HTML] Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic …
S Yang, X Li, F Yang, R Zhao, X Pan, J Liang… - Frontiers in …, 2019 - frontiersin.org
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target.
S Yang, X Li, F Yang, R Zhao, X Pan, J Liang, L Tian… - 2019 - cabidigitallibrary.org
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.
S Yang, X Li, F Yang, R Zhao, X Pan… - Frontiers in …, 2019 - europepmc.org
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
S Yang, X Li, F Yang, R Zhao, X Pan… - Gut Microbiota and …, 2021 - books.google.com
Atherosclerosis (AS) and resulting cardiovascular diseases (CVDs) are serious threats to
human health (Anderson et al., 1991; Vilahur et al., 2014). Multiple studies have identified a …
human health (Anderson et al., 1991; Vilahur et al., 2014). Multiple studies have identified a …
[引用][C] Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic …
S Yang, X Li, F Yang, R Zhao, X Pan, J Liang… - Frontiers in …, 2019 - cir.nii.ac.jp
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation
Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target | CiNii Research CiNii …
Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target | CiNii Research CiNii …
[PDF][PDF] Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic …
S Yang, X Li, F Yang, R Zhao, X Pan, J Liang, L Tian… - sochob.cl
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
[PDF][PDF] Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic …
S Yang, X Li, F Yang, R Zhao, X Pan, J Liang, L Tian… - chiro.org.au
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
S Yang, X Li, F Yang, R Zhao, X Pan… - Frontiers in …, 2019 - pubmed.ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
[HTML][HTML] Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic …
S Yang, X Li, F Yang, R Zhao, X Pan… - Frontiers in …, 2019 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.
S Yang, X Li, F Yang, R Zhao, X Pan… - Frontiers in …, 2019 - europepmc.org
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …
developed countries, and atherosclerosis (AS) is the common pathological basis of many …